Abnormal/JJ
T/NN
lymphocyte/NN
development/NN
induced/VBN
by/IN
targeted/VBN
overexpression/NN
of/IN
IkappaB/NN
alpha/NN
./.

A/DT
role/NN
in/IN
thymic/JJ
maturation/NN
for/IN
factors/NNS
of/IN
the/DT
NF-kappaB/NN
family/NN
has/VBZ
long/RB
been/VBN
suspected/VBN
,/,
but/CC
not/RB
yet/RB
proven/VBN
./.
=====
Transgenic/JJ
mice/NNS
with/IN
a/DT
lymphocyte-specific/JJ
defect/NN
in/IN
NF-kappaB/NN
activation/NN
were/VBD
produced/VBN
by/IN
targeted/VBN
expression/NN
of/IN
human/JJ
IkappaB/NN
alpha/NN
./.
=====
The/DT
thymic/JJ
cellularity/NN
of/IN
these/DT
mice/NNS
was/VBD
significantly/RB
decreased/VBN
./.
=====
The/DT
proportion/NN
of/IN
mature/JJ
,/,
TCRhigh/JJ
thymocytes/NNS
of/IN
the/DT
alphabeta/NN
lineage/NN
was/VBD
reduced/VBN
,/,
and/CC
the/DT
remaining/VBG
TCRhigh/JJ
population/NN
contained/VBD
an/DT
unusually/RB
high/JJ
proportion/NN
of/IN
double-positive/JJ
cells/NNS
./.
=====
This/DT
defect/NN
in/IN
maturation/NN
resulted/VBD
in/IN
a/DT
transgene/NN
dose-dependent/JJ
reduction/NN
in/IN
peripheral/JJ
T/NN
lymphocytes/NNS
,/,
with/IN
the/DT
CD8/NN
lineage/NN
being/VBG
more/RBR
severely/RB
affected/VBN
./.
=====
These/DT
data/NNS
provide/VBP
direct/JJ
evidence/NN
for/IN
the/DT
involvement/NN
of/IN
NF-kappaB/Rel/NN
family/NN
proteins/NNS
in/IN
late/JJ
stages/NNS
of/IN
T/NN
lymphocyte/NN
development/NN
,/,
coincident/JJ
with/IN
positive/JJ
and/CC
negative/JJ
selection/NN
./.